Amgen Inc., v. Chugai Pharmaceutical Co., Ltd., and Genetics Institute, Inc. (U.S. Court of Appeals - 927 F.2d 1200, Fed. Cir. 1991)

Case Description

The the Court of Appeals for the Federal Circuit held that for the patenting of microorganisms the best mode disclosure requirement does not necessarily entail an obligation by the patent applicant to deposit a sample of the claimed microorganism.

Decision Year
Pre-grant flexibilities